Bone marrow T-cell infiltration during acute GVHD is associated with delayed B-cell recovery and function after HSCT

Blood. 2014 Aug 7;124(6):963-72. doi: 10.1182/blood-2013-11-539031. Epub 2014 May 15.

Abstract

B-cell immune dysfunction contributes to the risk of severe infections after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Delayed B-cell regeneration is found in patients with systemic graft-versus-host disease (GVHD) and is often accompanied by bone marrow (BM) suppression. Little is known about human BM GVHD. We analyzed the reconstitution kinetics of B-cell subsets in adult leukemic patients within 6 months after allo-HSCT. B-cell deficiency already existed before transplant and was aggravated after transplant. Onset of B-cell reconstitution characterized by transitional B-cell recovery occurred either early (months 2-3) or late (from month 6 on) and correlated highly positively with reverse transcription-polymerase chain reaction quantified numbers of κ-deleting recombination excision circles (KRECs). Delayed recovery was associated with systemic acute GVHD and full-intensity conditioning therapy. Histological analysis of BM trephines revealed increased T-cell infiltration in late recovering patients, which was associated with reduced numbers of osteoblasts. Functionally, late recovering patients displayed less pneumococcal polysaccharide-specific immunoglobin M-producing B cells on ex vivo B-cell activation than early recovering patients. Our results provide evidence for acute BM GVHD in allo-HSCT patients with infiltrating donor T cells and osteoblast destruction. This is associated with delayed B-cell reconstitution and impaired antibody response. Herein, KREC appears suitable to monitor BM B-cell output after transplant.

MeSH terms

  • Acute Disease
  • Adult
  • Aged
  • Allografts
  • B-Lymphocyte Subsets / immunology*
  • B-Lymphocyte Subsets / pathology
  • Bone Marrow / immunology
  • Bone Marrow / pathology
  • Female
  • Gene Rearrangement, B-Lymphocyte, Light Chain
  • Graft vs Host Disease / etiology*
  • Graft vs Host Disease / immunology
  • Graft vs Host Disease / pathology
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Leukemia / immunology
  • Leukemia / pathology
  • Leukemia / therapy
  • Lymphocyte Activation
  • Male
  • Middle Aged
  • Osteoblasts / pathology
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / pathology
  • Time Factors
  • Young Adult